跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Karisa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Karisa
Approved
STANDARD
Karisa
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
33f13b4766e24f5c
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
33f13b4766e24f5c
Drug Approval Philippines Name
Karisa
Product Name
Karisa
Registration Number
DRP-14622-01
Brand Name
Karisa
Generic Name
Dabigatran Etexilate (as mesylate)
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Globela Pharma Private Limited
Distributor
Corbridge Group Phils., Inc.
Issuance Date
24 March 2024
Expiry Date
14 November 2028
Pharmacologic Category
Antithrombotic Agent (Direct Thrombin Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
33f13b4766e24f5c
Type
Standard
Back to Philippines FDA Approvals